Suppr超能文献

人OX-40配体的鉴定,一种与肿瘤坏死因子具有同源性的CD4+T细胞共刺激分子。

Identification of a human OX-40 ligand, a costimulator of CD4+ T cells with homology to tumor necrosis factor.

作者信息

Godfrey W R, Fagnoni F F, Harara M A, Buck D, Engleman E G

机构信息

Department of Pathology, Stanford University School of Medicine, California 94305.

出版信息

J Exp Med. 1994 Aug 1;180(2):757-62. doi: 10.1084/jem.180.2.757.

Abstract

The human OX-40 cell surface antigen is a CD4+ T cell activation marker that acts as a costimulatory receptor and is a member of the nerve growth factor receptor/tumor necrosis factor (TNF) receptor family. Using a soluble form of the receptor, the extracellular region fused with human immunoglobulin Fc, we expression cloned the human OX-40 ligand cDNA from a library derived from an activated B lymphoblastoid cell line MSAB. The encoded protein is identified as gp34, a type II transmembrane antigen previously known to be expressed only by human T cell lymphotropic virus 1-infected cells. We describe gp34 as a new member of the TNF family, and find that the recombinant ligand expressed in COS cells costimulates phorbol myristate acetate, phytohemagglutinin, and anti-CD3-induced CD4+ T cell proliferation.

摘要

人OX - 40细胞表面抗原是一种CD4 + T细胞活化标志物,作为共刺激受体,是神经生长因子受体/肿瘤坏死因子(TNF)受体家族的成员。我们使用受体的可溶性形式,即与人类免疫球蛋白Fc融合的细胞外区域,从活化的B淋巴母细胞系MSAB衍生的文库中表达克隆了人OX - 40配体cDNA。编码的蛋白质被鉴定为gp34,一种II型跨膜抗原,以前已知仅由人嗜T细胞病毒1感染的细胞表达。我们将gp34描述为TNF家族的新成员,并发现COS细胞中表达的重组配体可共刺激佛波醇肉豆蔻酸酯乙酸酯、植物血凝素和抗CD3诱导的CD4 + T细胞增殖。

相似文献

5
Identification of rat OX40 ligand by molecular cloning.通过分子克隆鉴定大鼠OX40配体。
Biochem Biophys Res Commun. 1998 Oct 9;251(1):131-6. doi: 10.1006/bbrc.1998.9376.
8
Characterization of rat OX40 ligand by monoclonal antibody.用单克隆抗体对大鼠OX40配体进行表征。
Biochem Biophys Res Commun. 2000 Apr 21;270(3):1041-8. doi: 10.1006/bbrc.2000.2560.

引用本文的文献

6
Association of gene polymorphism with multiple sclerosis in Iranians.伊朗人群中基因多态性与多发性硬化症的关联
Heliyon. 2024 Mar 5;10(6):e27304. doi: 10.1016/j.heliyon.2024.e27304. eCollection 2024 Mar 30.
10
Checkpoint: Inspecting the barriers in glioblastoma immunotherapies.检查点:检查胶质母细胞瘤免疫疗法中的障碍。
Semin Cancer Biol. 2022 Nov;86(Pt 3):473-481. doi: 10.1016/j.semcancer.2022.02.012. Epub 2022 Feb 10.

本文引用的文献

1
Emerging families of cytokines and receptors.新兴的细胞因子和受体家族。
Curr Biol. 1993 Sep 1;3(9):603-6. doi: 10.1016/0960-9822(93)90009-d.
7
Signals and signs for lymphocyte responses.淋巴细胞反应的信号与体征
Cell. 1994 Jan 28;76(2):275-85. doi: 10.1016/0092-8674(94)90335-2.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验